- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT06053645
Váha kardiovaskulárních onemocnění
Váha kardiovaskulárního onemocnění: Prospektivní pilotní studie obézních dospělých s kardiovaskulárním onemocněním hodnocená na nové kardiometabolické klinice
The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.
Přehled studie
Postavení
Podmínky
Typ studie
Zápis (Aktuální)
Kontakty a umístění
Studijní místa
-
-
Minnesota
-
Rochester, Minnesota, Spojené státy, 55905
- Mayo Clinic in Rochester
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Patients referred to the cardiometabolic clinic at Mayo Clinic Hospital in Rochester, MN will be recruited for participation.
Popis
Inclusion Criteria:
- BMI ≥30 kg/m2
- At least one of the following CVD: atrial fibrillation (AF), coronary artery disease (CAD), HFpEF (heart failure with preserved ejection fraction), HFrEF (heart failure with reduced ejection fraction), ACHD (adult congenital heart disease), or valvular heart disease
- Patients evaluated in the Cardiometabolic clinic
- Willingness to complete questionnaires/surveys
- Ability to complete monthly self-assessments at home
Exclusion Criteria:
- BMI <30 kg/m2
- Pregnancy or lactating women
- Hemodynamically unstable CVD
- Active malignancy
- Autoimmune or systemic inflammatory diseases
- Severe renal or hepatic failure
- Being considered unsafe to participate as determined by the study physician
- Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic medications, or other medications as determined by the study NP or physician
- Patients with active psychosis, mania, or substance use disorders
Studijní plán
Jak je studie koncipována?
Detaily designu
- Observační modely: COHORT
- Časové perspektivy: PROSPECTIVE
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Percent body weight loss
Časové okno: 12 months
|
Total percent body weight loss will be reported at 12 months based on the following formula: (Starting baseline weight minus current weight) / (starting baseline weight) x 100 equals % of body weight loss. |
12 months
|
|
Change in Body Mass Index (BMI)
Časové okno: Baseline, 12 months
|
Body Mass Index (BMI) will be calculated using the standard formula from participants' height and weight. BMI = (Weight in Pounds / (Height in inches x Height in inches)) x 703 |
Baseline, 12 months
|
|
Change in visceral adiposity distribution
Časové okno: Baseline, 12 months
|
Change in visceral adiposity distribution measured using dual energy X-ray absorptiometry (DEXA). |
Baseline, 12 months
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in Blood Pressure
Časové okno: Baseline, 12 months
|
Measured in millimeters of mercury (mmHg) |
Baseline, 12 months
|
|
Change in point of care glucose
Časové okno: Baseline, 12 months
|
Change in estimated glucose value (mg/dl) obtained from point of care fingerstick testing. |
Baseline, 12 months
|
|
Change in quality of diet
Časové okno: Baseline, 12 months
|
Change in quality of diet will be assessed by the Mini-EAT (Eating Assessment Tool). The Mini-EAT is a 9 item questionnaire that asks subjects how often they eat different types of foods (e.g. fruits, vegetables, legumes, etc.). Subjects respond on a scale of "I do not eat it at all" to "6 or more servings per day." Higher scores on the Mini-EAT represent a better quality of diet. |
Baseline, 12 months
|
|
Change in psychosocial distress as measured by Screening Tool for Psychological Distress (STOP-D)
Časové okno: Baseline, 12 months
|
Psychosocial distress will be measured by the STOP-D survey. The STOP-D survey asks subjects to rate how often over the last 2 weeks they have felt depressed, anxious, stressed, angry, or lacking social support on a scale of 0-Not at all to 9-Severely. Each item is scored separately without a summed score for overall distress. Higher individual scores on the STOP-D items represent worse psychosocial distress. |
Baseline, 12 months
|
|
Change in psychosocial distress as measured by Impact of Event Scale-Revised (IES-R)
Časové okno: Baseline, 12 months
|
Psychosocial distress will be measured by the IES-R. The IES-R is a questionnaire which asks subjects to rate how distressed or bothered during the past seven days they have been by difficulties that people sometimes have after stressful life events. Responses can range from 0-Not at all to 4-Extremely. Items on the questionnaire are grouped into 3 subscales: Intrusion, Avoidance, and Hyperarousal with scores on each subscale being the mean item response of all items in that group, thus scores for each subscale also range from 0 to 4. Higher scores are indicative of more psychosocial distress following the specific life event of focus. |
Baseline, 12 months
|
|
Change in psychosocial distress as measured by Adverse Childhood Experience (ACE) Questionnaire
Časové okno: Baseline, 12 months
|
Psychosocial distress will be measured by the ACE Questionnaire. The ACE Questionnaire asks subjects various questions regarding life experiences from the first 18 years of life that may be considered adverse experiences (e.g. parental abuse, neglect, parental divorce, etc.). Subjects answer each question with a yes or no selection. The more questions answered yes represents worse psychosocial distress. |
Baseline, 12 months
|
|
Change in functional aerobic capacity (VO2 Max)
Časové okno: Baseline, 12 months
|
VO2 Max is measured as milliliters of oxygen per kilogram of body weight per minute (ml/kg/min) during cardiopulmonary exercise test |
Baseline, 12 months
|
|
Change in artificial intelligence electrocardiogram (AI-ECG) age
Časové okno: Baseline, 12 months
|
AI-ECG age is the subject's predicted age based on artificial intelligence analysis of electrocardiograms (ECGs). |
Baseline, 12 months
|
|
Change in E/e'
Časové okno: Baseline, 12 months
|
E/e' will be measured using transthoracic echocardiography (TTE). It is defined as the ratio of peak early diastolic mitral inflow velocity (E) and peak early diastolic mitral annular velocity (e') and will be used to assess left ventricular diastolic function. |
Baseline, 12 months
|
|
Change in Peak Tricuspid Regurgitation (TR) Velocity
Časové okno: Baseline, 12 months
|
Peak TR Velocity (m/s) will be measured using transthoracic echocardiography (TTE) to assess left ventricular diastolic function. |
Baseline, 12 months
|
|
Change in Right Atrial (RA) Pressure
Časové okno: Baseline, 12 months
|
RA pressure (mm Hg) will be measured by transthoracic echocardiography (TTE) to assess left ventricular diastolic function. |
Baseline, 12 months
|
|
Change in Left Atrial (LA) volume index
Časové okno: Baseline, 12 months
|
LA volume index (ml/m^2) will be measured by transthoracic echocardiography (TTE) to assess left ventricular diastolic function. |
Baseline, 12 months
|
|
Change in physical activity
Časové okno: Baseline, 12 months
|
Average number of steps a subject takes daily as collected by an Apple watch worn by subjects for the duration of the study. |
Baseline, 12 months
|
|
Change in heart rate with detection of arrhythmia
Časové okno: Baseline, 12 months
|
Average number of arrhythmias identified by an Apple watch worn by subjects for the duration of the study. |
Baseline, 12 months
|
|
Change in cardio fitness
Časové okno: Baseline, 12 months
|
Fitness level reported as high/above average/below average/low as collected by an Apple watch worn by subjects for the duration of the study. |
Baseline, 12 months
|
|
Change in six-minute walk test
Časové okno: Baseline, 12 months
|
Measurement (meters) of distance a person can walk on flat ground in 6 minutes collected by an Apple watch worn by subjects for the duration of the study. |
Baseline, 12 months
|
|
Change in psychosocial distress as measured by the Weight Bias Internalization-Modified (WBIS-M) scale
Časové okno: Baseline, 12 months
|
The WBIS-M is a 11-item instrument for measuring the extent to which overweight individuals think of themselves in terms of prevalent negative stereotypes about overweight and overweight individuals. Respondents can express their level of agreement on a 7-point Likert scale ranging from 'strongly disagree' (1) to 'strongly agree' (7). Items 1 and 9 need to be scored reversely. Scores are averaged to create a composite score and higher scores represent greater psychosocial distress. |
Baseline, 12 months
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Kyla Lara-Breitinger, M.D., Mayo Clinic
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 26-008806
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .